Amresh Kumar - May 6, 2024 Form 4 Insider Report for Acasti Pharma Inc. (ACST)

Role
VP Clinical Operations
Signature
/s/ Carrie D'Andrea
Stock symbol
ACST
Transactions as of
May 6, 2024
Transactions value $
$0
Form type
4
Date filed
5/8/2024, 07:19 PM
Previous filing
Jul 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +19.7K $0.00 19.7K May 6, 2024 Class A Common Shares 19.7K $2.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period.